317 employees
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
2017
$100M
from 1 investors over 1 rounds
Urovant Sciences, Inc. raised $100M on February 22, 2019
Investors: Hercules Capital, Inc.